Chengdu, China

Fengchun Chen

This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignee: Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd.. Active years: 2021.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Fengchun Chen. Retrieved from https://idiyas.com/inventor/fengchun-chen-b8z06wrx

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

 

Average Co-Inventor Count = 8.0

ph-index = 1


Company Filing History:


Years Active: 2021

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovations of Fengchun Chen

Introduction

Fengchun Chen is a notable inventor based in Chengdu, China. He has made significant contributions to the field of pharmaceuticals, particularly in the development of innovative compounds for medical use. His work focuses on addressing critical health issues through novel chemical formulations.

Latest Patents

Fengchun Chen holds 1 patent for his invention titled "Solid form of azetidine derivative and preparation method therefor and use thereof." This patent relates to a solid form of a compound designed to treat Janus kinase (JAK) related diseases, including inflammatory diseases, autoimmune diseases, and cancers. The invention encompasses a method for preparing the solid form, a pharmaceutical composition that includes the solid form, and its applications in medical treatments.

Career Highlights

Fengchun Chen is currently associated with Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. His role in the company allows him to leverage his expertise in biopharmaceuticals to develop innovative solutions for complex health challenges. His contributions have been instrumental in advancing the company's research and development efforts.

Collaborations

Fengchun Chen collaborates with talented professionals in his field, including Ping Zhang and Lichun Wang. These collaborations enhance the research environment and foster innovation within the company.

Conclusion

Fengchun Chen's work exemplifies the spirit of innovation in the pharmaceutical industry. His patent for a solid form of azetidine derivative showcases his commitment to developing effective treatments for serious health conditions. Through his career at Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd., he continues to make impactful contributions to medical science.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…